Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | epirizole | 164739 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | epirizole | 164739 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | epirizole | 164739 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | epirizole | 164739 | drug-path |
| Asthma | R-HSA-444620 | map05310 | epirizole | 164739 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | epirizole | 164739 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | imipramine | 3696 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | imipramine | 3696 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | imipramine | 3696 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | imipramine | 3696 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | imipramine | 3696 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | imipramine | 3696 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | imipramine | 3696 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | imipramine | 3696 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | homatropine | 174174 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | homatropine | 174174 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | homatropine | 174174 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | homatropine | 174174 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | homatropine | 174174 | drug-path |
| Shigellosis | 0 | map05131 | allantoin | 204 | drug-path |